Republication de : Évaluation de la mise en application des recommandations 2021 de la Société Européenne de Cardiologie pour l'insuffisance cardiaque à fraction d'éjection réduite chez les patients âgés de plus de 75 ans

Annales de Cardiologie et d'Angeiologie - Tập 72 - Trang 101680 - 2023
Marianne Dacunka1, Stéphane Sanchez2,3, Florian Raoul1, Laurent Chapoutot1, Bruno Maillier1, Aurélie Marchais1
1Service de cardiologie, Centre Hospitalier de Troyes, Troyes France
2Pôle territoriale Santé Publique et Performance, Centre Hospitalier de Troyes, Troyes France
3Vieillissement fragilité, Université de Reims Champagne-Ardenne, Reims, EA3797 France

Tài liệu tham khảo

Gabet, 2015, National trends in rate of patients hospitalized for heart failure and heart failure mortality in France, 2000-2012: Trends in hospitalization rates for HF and HF mortality in France, Eur J Heart Fail, 17, 583, 10.1002/ejhf.284 Emmons-Bell, 2022, Prevalence, incidence and survival of heart failure: a systematic review, Heart, 108, 1351, 10.1136/heartjnl-2021-320131 Caractéristiques et trajet de soins des insuffisants cardiaques du Régime général [Internet]. [cité 23 janv 2023]. 2023 Disponible sur: https://assurance-maladie.ameli.fr/sites/default/files/2012-08_caracteristiques-trajet-soins-insuffisants-cardiaque_points-de-repere-38_assurance-maladie.pdf McDonagh, 2021, 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, Eur Heart J, 42, 3599, 10.1093/eurheartj/ehab368 Ponikowski, 2016, Eur Heart J, 37, 2129, 10.1093/eurheartj/ehw128 McMurray, 2019, Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction, N Engl J Med, 381, 1995, 10.1056/NEJMoa1911303 Packer, 2020, Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure, N Engl J Med, 383, 1413, 10.1056/NEJMoa2022190 Mebazaa, 2022, Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial, Lancet, 400, 1938, 10.1016/S0140-6736(22)02076-1 Funck-Brentano, 2001, Predictors of medical events and of their competitive interactions in the Cardiac Insufficiency Bisoprolol Study 2 (CIBIS-2), Am Heart J, 142, 989, 10.1067/mhj.2001.118741 Rogers, 1991, Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure, N Engl J Med, 325, 293, 10.1056/NEJM199108013250501 Pitt, 1999, The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure, N Engl J Med, 341, 709, 10.1056/NEJM199909023411001 Zannad, 2011, Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms, N Engl J Med, 364, 11, 10.1056/NEJMoa1009492 McMurray, 2014, Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure, N Engl J Med, 371, 993, 10.1056/NEJMoa1409077 Logeart, 2013, Current aspects of the spectrum of acute heart failure syndromes in a real-life setting: the OFICA study, Eur J Heart Fail, 15, 465, 10.1093/eurjhf/hfs189 Roy, 2008, Rhythm control versus rate control for atrial fibrillation and heart failure, N Engl J Med, 358, 2667, 10.1056/NEJMoa0708789 Cohen-Solal, 2022, Iron deficiency in heart failure patients: the French CARENFER prospective study, ESC Heart Fail, 9, 874, 10.1002/ehf2.13850 McDonagh, 2018, Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice, Eur J Heart Fail, 20, 1664, 10.1002/ejhf.1305 Sin, 2002, The Effects of Beta-blockers on Morbidity and Mortality in a Population-Based Cohort of 11,942 Elderly Patients with Heart Failure, Am J Med, 113, 650‑6, 10.1016/S0002-9343(02)01346-3 Flather, 2005, Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS), Eur Heart J, 26, 215, 10.1093/eurheartj/ehi115 Jarjour, 2020, Care Gaps in Adherence to Heart Failure Guidelines, JACC: Heart Fail, 8, 725 Girerd, 2022, Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction, ESC Heart Failure, 9, 2063, 10.1002/ehf2.13929 Gonseth, 2004, The effectiveness of disease management programmes in reducing hospital re-admission in older patients with heart failure: a systematic review and meta-analysis of published reports, Eur Heart J, 25, 1570, 10.1016/j.ehj.2004.04.022 2011, Therapeutic education in patients with chronic heart failure: proposal for a multiprofessional structured programme, by a French Task Force under the auspices of the French Society of Cardiology, Arch Cardiovasc Dis, 104, 189, 10.1016/j.acvd.2010.12.003